Related Experiment Video
Updated: May 6, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
Gross total resection improves overall survival in children with choroid plexus carcinoma
Matthew Z Sun1, Michael E Ivan, Aaron J Clark
1Department of Neurological Surgery, University of California San Francisco, 505 Parnassus Ave., San Francisco, CA, 94117, USA.
Insights
Gross total resection (GTR) significantly improves overall survival for pediatric choroid plexus carcinoma (CPC) patients. This finding supports GTR when safely achievable, offering a crucial survival benefit for children with this rare brain tumor.
Area of Science:
- Pediatric neuro-oncology
- Surgical oncology
- Brain tumor research
Background:
- Choroid plexus carcinoma (CPC) is a rare pediatric brain tumor with a poor prognosis.
- Limited large-scale studies focus on surgical extent in pediatric CPC.
- Balancing surgical risks and benefits is critical in pediatric neurosurgery.
Purpose of the Study:
- To systematically review pediatric CPC cases.
- To evaluate the impact of gross total resection (GTR) on overall survival (OS) and progression-free survival (PFS).
- To provide evidence-based recommendations for surgical management of pediatric CPC.
Main Methods:
- Systematic review of pediatric CPC cases from Pubmed.
- Inclusion of disaggregated clinical data with confirmed resection extent (CT/MRI).
- Kaplan-Meier and multivariate Cox regression survival analyses.
Main Results:
- Analysis of 102 pediatric CPC patients (age ≤18 years).
- GTR significantly associated with improved OS (logrank p < 0.001) and independently predicted better OS (p = 0.006) in multivariate analysis.
- GTR showed a trend towards improved PFS (p = 0.027) but did not reach statistical significance in the multivariate model (p = 0.120).
Conclusions:
- Gross total resection (GTR) is a significant independent predictor of improved overall survival in pediatric choroid plexus carcinoma.
- GTR is recommended for pediatric CPC when it can be safely performed.
- Further research may explore factors influencing PFS after GTR in pediatric CPC.
Abstract:
Choroid plexus carcinoma (CPC) is a rare, malignant, primary brain tumor with a poor prognosis. While previous reports have shown benefits of aggressive surgery, very few large-scale studies have focused exclusively on the pediatric population, for whom the risks of aggressive surgery must be weighed carefully against the benefits. We performed a comprehensive systematic review of pediatric CPCs to test the effects of gross total resection (GTR) on overall survival (OS) and progression-free survival (PFS). A Pubmed search was performed to identify children with CPC who underwent surgical resection. Only disaggregated clinical cases in which extent of resection was confirmed by CT or MRI were included for analysis. Kaplan-Meier and multivariate Cox regression survival analyses were performed to determine the effects of extent of resection on OS and PFS. Disaggregated clinical data from a total of 102 pediatric CPC patients (age ≤18 years) with known extent of resection and overall survival were analyzed. GTR was significantly associated with better OS by Kaplan-Meier analysis (logrank p < 0.001). Multivariate Cox regression analysis adjusting for age, gender, tumor location (supratentorial vs. infratentorial), and type of adjuvant therapy (chemotherapy, radiation, and combined therapy), showed that GTR independently increased OS (p = 0.006). While GTR also improved PFS on Kaplan-Meier analysis (p = 0.027), the effect did not meet our criteria for significance in our multivariate Cox model (p = 0.120). GTR improved OS of pediatric CPC and is recommended if it can be safely performed.
More Related Videos
13:57Laparoscopic Anatomical Liver Segment VII Resection with Liver Parenchymal Transection Following a Priority Approach
Published on: May 23, 2025
05:22Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
Published on: February 13, 2026